2.Effect of L-arginine on Pax2 expression in the kidneys of pup rats with intrauterine growth retardation.
Jian-Fang GE ; Zong-De XIE ; Wen LI ; Su-Ping LI ; Jin-Tao HU
Chinese Journal of Contemporary Pediatrics 2011;13(2):145-148
OBJECTIVETo study the effect of L-arginine (L-Arg) on Pax2 expression in the kidneys of pup rats with intrauterine growth retardation (IUGR).
METHODSPregnant rats were randomly assigned into three groups:normal, IUGR and L-Arg treated IUGR. The rats in the normal group were fed with ordinary forage (21% protein) during pregnancy. Those in the other two groups were fed with low diet forage (10% protein) during pregnancy. The L-Arg treated group was given drinking water containing L-Arg (200 mg/kg) daily during 21 days of lactation. Pax2 expression in renal tissues was measured with immunohistochemical staining and Western blot in pup rats of 7 days, 21 days, 2 months and 3 months old.
RESULTSThe immunohistochemical staining showed that Pax2 was not expressed in the pup rats from the normal group at any time point. Pax2 positive cells were found in renal glomerulus and kidney tubules of 2-months- and 3-months-old rats from the IUGR and L-Arg treated groups. And Pax2 expression in 3-months-old rats was significantly higher than that in 2-months-old rats (P<0.05). L-Arg treatment decreased significantly the Pax2 expression in 2-months- and 3-months-old rats when compared with the untreated IUGR group (P<0.05). Western blot showed that Pax2 protein was not expressed in 7-days- and 21-days-old pup rats from three groups. Pax2 protein expression in 2-months- and 3-months-old pup rats from the IUGR and L-Arg treated groups increased significantly compared with normal controls. Pax2 protein expression in the pup rats from the L-Arg treated group was significantly lower than that in the untreated IUGR pup rats (P<0.01).
CONCLUSIONSPax2 is expressed in the kidneys of IUGR rats during adulthood. L-Arg treatment can decrease the expression of Pax2.
Animals ; Arginine ; pharmacology ; Blotting, Western ; Female ; Fetal Growth Retardation ; metabolism ; Immunohistochemistry ; Kidney ; chemistry ; Male ; PAX2 Transcription Factor ; analysis ; Rats ; Rats, Sprague-Dawley
3.Changes of hemodynamics and concentrations of nitric oxide, endothelin, prostacyclin, and thromboxane A2 during portal cavity clamping and opening in portal hypertensive canines.
Xin-Jin CHI ; Jian-Qi WEI ; Zi-Qing HEI ; Mian GE ; De-Zhao LIU
Journal of Southern Medical University 2009;29(7):1337-1340
OBJECTIVETo observe the changes in systemic hemodynamics and their relations to the concentrations of nitric oxide, endothelin, prostacyclin, and thromboxane A2 after portal cavity clamping and opening in portal hypertensive canines.
METHODSTwelve canines were randomly divided into control group and model group, and partial ligation of the portal vein was performed in the model group. Portal cavity clamping and opening was performed 12 weeks later in the two groups. The hemodynamic parameters including cardiac output index (CI), heart rate (HR), mean artery blood pressure (MABP), central venous pressure (CVP), pulmonary arteriole wedge pressure (PAWP), and systemic vascular resistance index (SVRI) were measured during the operation. Samples were obtained from the central vein at 3 time points during the operation for measuring NO, ET, PGI2, and TXA2.
RESULTSPortal vein ligation and portal cavity clamping produced obvious changes in the systemic circulation of the dogs, and the alteration was milder in the control group. After obstruction of the portal vein, the NO levels in systemic circulation in portal hypertensive dogs declined obviously, but gradually recovered the normal level after reperfusion.
CONCLUSIONSystemic circulation undergoes significant alterations after portal vein obstruction, but its changes in portal hypertensive dogs are milder than those in the control group, the mechanism of which needs further investigation.
Animals ; Disease Models, Animal ; Dogs ; Endothelins ; blood ; Epoprostenol ; blood ; Hemodynamics ; Hypertension, Portal ; blood ; physiopathology ; Nitric Oxide ; blood ; Plasma ; metabolism ; Portal Vein ; physiopathology ; Thromboxane A2 ; blood ; Vena Cava, Inferior ; physiopathology
4.Cloned goats produced from the somatic cells of an adult transgenic goat.
Yong CHENG ; Yu-Ge WANG ; Jin-Ping LUO ; Yu SHEN ; Yue-Fei YANG ; Hui-Ming JU ; Xian-Gang ZOU ; Shao-Fu XU ; Wei-De LAO ; Miao DU
Chinese Journal of Biotechnology 2002;18(1):79-83
This study was carried out to examine the effect of different donor cell type and micro-manipulation on the development of reconstituted embryos. Cultured mural cumulus cells or fibroblast cells from an adult transgenic goat expressing human erythropoietin(rhEPO) were used as the donor cells in nuclear transfer experiments. The reconstituted eggs were generated by transferring fibroblast cells or cumulus cells into the perivitelline space of enucleated M II oocytes and then followed by electrofusion and activation. After 6 days' incubation in vivo, the reconstructed embryos developed into morulae or blastocysts were transferred into 6 foster recipients. Two of the foster-mothers were pregnant and gave birth to two offspring, which were derived from the fibroblast cell and cumulus cell, respectively. Fingerprint analysis showed that the PCR-RFLP patterns of the two offspring were identical to that of donor goats. PCR results indicated that these cloned goats carried hEPO gene as same as their donor cells.
Animals
;
Animals, Genetically Modified
;
genetics
;
Cell Fusion
;
methods
;
Cloning, Organism
;
Embryo Transfer
;
trends
;
Erythropoietin
;
biosynthesis
;
genetics
;
Fibroblasts
;
cytology
;
Goats
;
embryology
;
genetics
;
Humans
;
Microinjections
;
methods
;
Nuclear Transfer Techniques
;
Oocytes
;
cytology
5.Fertilization rates following 109 half intracytoplasmic sperm injection cycles for in vitro fertilization-embryo transfer.
Xin-yu GUO ; Jin-yu ZHNAG ; De-wei LIN ; Yan YU ; Ming-xiao GE
Journal of Southern Medical University 2010;30(8):1920-1922
OBJECTIVETo evaluate the clinical outcomes of half intracytoplasmic sperm injection (partial ICSI) treatment in infertile patients with potential fertilization failure.
METHODSA total of 109 partial ICSI cycles of in vitro fertilization-embryo transfer (IVF-ET) were classified into 5 groups, namely group A (infertile patients for unidentified causes, 17 cycles), group B (oligo-asthenozoospermia patients, 28 cycles), group C (teratozoospermia patients, 8 cycles), group D (primary infertile patients without definite causes, 31 cycles), and group E (secondary infertile patients without definite causes, 25 cycles). The fertilization rate and normal fertilization rate after IVF and ICSI were compared between the groups.
RESULTSSignificant differences were found in the fertilization rate following conventional IVF and ICSI in group A (53.1-/+38.8% vs 72.2-/+34.1%) and group D (58.8-/+31.6% vs 82.7-/+21.4%) (P<0.05), but not in groups B, C and E (P>0.05). The normal fertilization rates following IVF and ICSI in groups A, B, D, E were statistically different (P<0.05), but similar in group C (P>0.05).
CONCLUSIONICSI treatment may increase the fertilization rate of IVF-ET in patients with unexplained infertility and primary infertility, but not in patients with oligo-asthenozoospermia, teratozoospermia or secondary infertility.
Adult ; Asthenozoospermia ; Embryo Transfer ; Female ; Humans ; Infertility, Male ; therapy ; Male ; Pregnancy ; Pregnancy Outcome ; Retrospective Studies ; Sperm Injections, Intracytoplasmic ; Spermatozoa ; abnormalities
6.Effects of histamine on endothelial nitric oxide synthase expression in pulmonary artery endothelial cells.
De-Qin LU ; Hui-Ge LI ; Hong YE ; Shi-Qiao YE ; Si JIN ; Di-Xun WANG
Acta Physiologica Sinica 2004;56(3):288-294
All three nitric oxide synthase (NOS) isoforms are found in the lungs. It has been demonstrated that eNOS-derived NO plays an important role in modulating pulmonary vascular tone and inhibiting pulmonary vascular remodeling. Histamine induces pulmonary vasoconstriction by activating H(1)-receptor on the smooth muscle cells and vasodilation by stimulating H(2)-receptor. It remains unclear whether histamine also modulates the pulmonary vascular tone by regulating eNOS gene expression and NO production in pulmonary artery endothelial cells. Therefore, the present study was performed on cultured primary porcine pulmonary artery endothelial cells (PAECs) to investigate the effects of histamine on eNOS gene expression, and to explore the role of CaMK II in eNOS gene expression. After treatment with different concentrations histamine for different times, the levels of eNOS mRNA and protein were measured by RT-PCR and Western blot, respectively. The results showed that histamine upregulated eNOS mRNA and protein levels in a concentration- and time-dependent manner. Incubation with 10 micromol/L histamine for 24 h could increase eNOS mRNA and protein level to 160.8+/-12.2% (P<0.05) and 136.2+/-11.2% (P<0.05), respectively, of the control values. These up-regulation effects were prevented by selective CaMK II inhibitor, KN-93 (10 micromol/L). To investigate whether or not histamine increases eNOS expression by upregulating eNOS gene transcription, PAECs were transiently transfected with 1.6-kb fragment of the human eNOS promoter driving a luciferase reporter gene. The results suggested that eNOS gene promoter activity was enhanced to 148.2+/-33.7% (P<0.05) of the control after PAECs were incubated with 10 micromol/L histamine for 24 h. The nitrite and nitrate content in culture media measured by colorimetric method after incubation with 10 micromol/L histamine for 24 h indicated that the NO production in PAECs was increased. These results suggest that histamine up-regulates eNOS gene transcription and enhances NO production in PAECs by a signaling pathway involving CaMK II, which might be one of the mechanisms of histamine modulating pulmonary vascular tone.
Animals
;
Calcium-Calmodulin-Dependent Protein Kinase Type 2
;
Calcium-Calmodulin-Dependent Protein Kinases
;
pharmacology
;
Cells, Cultured
;
Endothelium, Vascular
;
enzymology
;
Histamine
;
pharmacology
;
Nitric Oxide Synthase Type III
;
biosynthesis
;
genetics
;
Promoter Regions, Genetic
;
Pulmonary Artery
;
cytology
;
enzymology
;
RNA, Messenger
;
biosynthesis
;
genetics
;
Swine
;
Up-Regulation
7.Ultrastructural characteristics of SARS associated virus in infected cells.
Cui-e WANG ; Yu-chuan LI ; Xiao-hong WU ; Jun-tian CAO ; Ge YAN ; Jin-feng LI ; Bing-yin SI ; Man YU ; E-de QIN ; Qing-yu ZHU
Chinese Journal of Pathology 2003;32(3):209-211
OBJECTIVEElectron microscopical study of infected cells to identify the pathogenic agent of SARS.
METHODSVero E6 cells infected with lung autopsy samples or nasopharyngeal swabs from SARS patients of Beijing and Guangzhou were inoculated. The supernatant and cultured cells exhibiting identifiable cytopathic effect (CPE) were prepared for electron microscopic study.
RESULTSExamination of CPE cells on thin-section revealed characteristic coronavirus particles within the cisternae of endoplasmic reticulum, Golgi apparatus, vesicles and extracellular space. They were mainly spherical or oval in shape, annular or dense, about 80 nm in diameter. Negative-stain electron microscopy identified coronavirus particles in culture supernatant, 80 - 120 nm in diameter, with club-shaped surface projections. Elongated, rod-, kidney- or other irregular shaped virons with the size of 100 - 200 nm by 60 - 90 nm were also found in the cultured cells infected with the lung samples from the Guangdong patients. Infectious virons entered cells by endocytosis or membrane fusion and released through a budding process.
CONCLUSIONThese data indicate a novel coronavirus as the causative agent of SARS. Most viral particles showed typical characteristics of coronavirus. The potential role of special shape viruses is expected to be further investigated.
Animals ; Cercopithecus aethiops ; Humans ; Microscopy, Electron ; SARS Virus ; ultrastructure ; Severe Acute Respiratory Syndrome ; virology ; Vero Cells
8.Comparison of therapeutic effect of different doses of ganciclovir for neonatal congenital cytomegalovirus infection.
Xiao-Ri HE ; Ping-Yang CHEN ; Tao WANG ; Zong-De XIE ; Jin-Tao HU ; Tao BO ; Jian-Fang GE
Chinese Journal of Contemporary Pediatrics 2009;11(8):641-644
OBJECTIVEGanciclovir is a first-line drug for treatment of cytomegalovirus (CMV) infection. However, some ganciclovir treatment-related side-effects can be found. This study aimed to compare the efficacy and side effects of relatively low and high doses of ganciclovir in the treatment of neonatal congenital CMV infection.
METHODSOne hundred and sixty-seven neonates with congenital CMV infection were randomly assigned to high-dose (n=79) and low-dose ganciclovir groups (n=88). The high-dose ganciclovir group was injected with ganciclovir of 7.5 mg/kg in the inducement phase and of 10 mg/kg in the maintaining phase. The low-dose ganciclovir group was injected with ganciclovir of 5 mg/kg in the inducement and the maintaining phases. The efficacy and side effects were observed in the two groups.
RESULTSAfter treatment the clinical symptoms and signs were obviously improved in both groups. CMV-IgM became negative in 93.8% of neonates in the high-dose ganciclovir group and 93.1% of neonates in the low-dose ganciclovir group (P>0.05). CMV-DNA became negative in 80.8% of neonates in the high-dose ganciclovir group and in 86.7% in the low-dose ganciclovir group (P>0.05). The low-dose ganciclovir group had lower incidence of side effects than the high-dose ganciclovir group: vomiting 2.3% vs 11.4%; anemia 8.0% vs 20.3%; reduction of neutrophilic granulocytes 5.7% vs 16.5%; increase in platelet count 8.0% vs 18.9% (P<0.05).
CONCLUSIONSLow-dose ganciclovir has the same clinical efficacy to high-dose ganciclovir for treatment of neonatal congenital CMV infection, but fewer side effects occur in the low-dose group.
Antiviral Agents ; administration & dosage ; Cytomegalovirus Infections ; congenital ; drug therapy ; DNA, Viral ; analysis ; Dose-Response Relationship, Drug ; Female ; Ganciclovir ; administration & dosage ; adverse effects ; Humans ; Infant, Newborn ; Male
9.Preparation and mechanical properties analysis of porous biological ceramics and PVA hydrogel composite material
Jin long LIU ; De kun ZHANG ; Shi rong GE
Journal of Medical Biomechanics 2011;26(4):E341-E348
Objective To cross-link the porous biological ceramics and PVA hydrogel to form a double layer construction between the artificial cartilage and hard joint, and to analyze its morphologies and mechanical properties. Methods With hydroxyl apatite (HA) as the substrate, the porous hydroxyl apatite biological ceramics with different porosities were prepared by using NH4HCO3 crystal grains as the pore-formed material. The poly vinyl alcohol (PVA) and epoxypropane were used as the primary material and cross-linking agent, respectively. The PVA hydrogel with double layer construction was cross-linked and prepared on the porous biological ceramics surface. The fracture appearances of the test specimen section were characterized. The performances of anti tensile strength and anti-shear strength for PVA hydrogel were analyzed. Results The cross-linked PVA hydrogel could permeate in the biological ceramics substrate, and the union between ceramic substrate and PVA hydrogel performed well. With the porosity of the porous biological ceramics increasing, the tension load and shear load of the PVA hydrogel samples both increased, and with the average porosity of 70%, the samples’ biggest tension load and shear load were 153.61 N and 64.46 N, respectively. But the corresponding tensile strength and shear strength both decreased and with the average porsity of 70%, the samples’ biggest tensile strength and shear strength were 2.12 MPa and 1.13 MPa, respectively. The failure mode of both tension and shear tests for PVA hydrogel samples was due to the crack propagation, and the fracture morphologies showed that obvious cracks and internal defects appeared on the fracture surface, while the source of the crack and the direction of the crack propagation could be observed. Conclusions Considering the compression strength of porous biological ceramics, the permeation effect on the porous biological ceramic substrate with the average porosity of 50% is moderate to be used, which ensures the appropriate shear and tensile strength of PVA hydrogel samples and the compression strength of porous biological ceramic.
10.Inadequate glycaemic control and antidiabetic therapy among inpatients with type 2 diabetes in Guangdong Province of China.
Yan BI ; Jin-hua YAN ; Zhi-hong LIAO ; Yan-bing LI ; Long-yi ZENG ; Kuan-xiao TANG ; Yao-ming XUE ; Hua-zhang YANG ; Lu LI ; De-hong CAI ; Ge WU ; Fan ZHANG ; Shao-da LIN ; Zheng-hua XIAO ; Da-long ZHU ; Jian-ping WENG
Chinese Medical Journal 2008;121(8):677-681
BACKGROUNDDiabetes mellitus has become epidemic in recent years in China. We investigated the prevalence of hyperglycaemia and inadequate glycaemic control among type 2 diabetic inpatients from ten university teaching hospitals in Guangdong Province, China.
METHODSInadequate glycaemic control in diabetic patients was defined as HbA1c = 6.5%. Therapeutic regimens included no-intervention, lifestyle only, oral antiglycemic agents (OA), insulin plus OA (insulin + OA), or insulin only. Antidiabetic managements included monotherapy, double therapy, triple or quadruple therapy.
RESULTSAmong 493 diabetic inpatients with known history, 75% had HbA1c = 6.5%. Inadequate glucose control rates were more frequently seen in patients on insulin + OA regimen (97%) than on OA regimen (71%) (P < 0.001), and more frequent in patients on combination therapy (81% - 96%) than monotherapy (75%) (P < 0.05). Patients on insulin differed significantly from patients on OA by mean HbA1c, glycemic control rate, diabetes duration, microvascular complications, and BMI (P < 0.01).
CONCLUSIONSThis study showed that glycaemic control of type 2 diabetic patients deteriorated for patients who received insulin and initiation time of insulin was usually delayed. It is up to clinicians to move from the traditional stepwise therapy to a more active and early combination antidiabetic therapy to provide better glucose control.
Aged ; China ; epidemiology ; Diabetes Mellitus, Type 2 ; blood ; drug therapy ; Female ; Glycated Hemoglobin A ; analysis ; Humans ; Hyperglycemia ; epidemiology ; Hypoglycemic Agents ; administration & dosage ; Inpatients ; Male ; Middle Aged